I would not know, mate.
It could be that the MoA is similar to Dexrazoxane, or it could be something new entirely.
There is this new research that emerged recently investigating human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). The researchers ran a bunch of tests and found iPSC-CMs from diffferent patients were either sensitive or resistant to doxorubicin-induced cardiotoxicity. DND microRNA-mediated repression inhibitor 1 (DND1) was shown to be a differentially expressed gene that determined sensitivity/resistance.
It could very well be that Zantrene targets this mechanism causing increased resistance to doxorubicin-induced cardiotoxicity.
I would not know, mate. It could be that the MoA is similar to...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.77 |
Change
0.195(12.4%) |
Mkt cap ! $287.5M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.80 | $1.58 | $412.1K | 243.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5207 | $1.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 4495 | 2 |
View Market Depth
| Last trade - 14.13pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.72 |
Change
0.195 ( 9.60 %) |
||||
| Open | High | Low | Volume | ||
| $1.60 | $1.80 | $1.58 | 16561 | ||
| Last updated 14.34pm 06/06/2024 ? | |||||
| RAC (ASX) Chart |